Resource Library
|
|
|
|||||||||||||||||||||
|
Powered by:
This information is provided by an independent source. Merck & Co., Inc. is not responsible for this content. Please discuss any and all treatment options with your healthcare professional. The manufacturer of a product generally has the most complete information about that product.
Diabetic retinopathyDefinitionDiabetic retinopathy is damage to the eye's retina that occurs with long-term diabetes. See also: Alternative NamesRetinopathy - diabetic; Photocoagulation - retina CausesDiabetic retinopathy is caused by damage to blood vessels of the retina. The retina is the layer of tissue at the back of the inner eye. It changes light and images that enter the eye into nerve signals that are sent to the brain.
There are two types, or stages of retinopathy: non-proliferative or proliferative.
Other problems that may develop are:
Diabetic retinopathy is the leading cause of blindness in working-age Americans. People with both type 1 diabetes and type 2 diabetes are at risk for this condition. Having more severe diabetes for a longer period of time increases the chance of getting retinopathy. Retinopathy is also more likely to occur earlier and be more severe if your diabetes has been poorly controlled. Almost everyone who has had diabetes for more than 30 years will show signs of diabetic retinopathy. SymptomsMost often, diabetic retinopathy has no symptoms until the damage to your eyes is severe. Symptoms of diabetic retinopathy include:
Many people with early diabetic retinopathy have no symptoms before major bleeding occurs in the eye. This is why everyone with diabetes should have regular eye exams. Exams and TestsIn nearly all cases, the health care provider can diagnose diabetic retinopathy by dilating the pupils with eye drops and then carefully examining the retina. A retinal photography or fluorescein angiography test may also be used. TreatmentThis version of the Encyclopedia has no treatment information. Please discuss any and all treatment options for your condition with your healthcare professional. Support GroupsAmerican Diabetes Association - www.diabetes.org National Diabetes Information Clearinghouse - www.diabetes.niddk.nih.gov Prevent Blindness America - www.preventblindness.org Outlook (Prognosis)You can improve your outcome by keeping good control of your blood sugar and blood pressure. Both treatments are effective at reducing vision loss. They do not cure diabetic retinopathy or reverse the changes that have already occurred. Once proliferative retinopathy occurs, there is always a risk for bleeding. You will need ongoing monitoring, and you may need more treatment. Possible Complications
When to Contact a Medical ProfessionalCall for an appointment with an eye doctor (ophthalmologist) if you have diabetes and you have not seen an ophthalmologist in the past year. Call your doctor if any of the following symptoms are new or are becoming worse:
PreventionTight control of blood sugar, blood pressure, and cholesterol is very important for preventing diabetic retinopathy. Do not smoke. If you need help quitting, ask your doctor or nurse. You may not know there is any damage to your eyes until the problem is very bad. Your doctor can catch problems early if you get regular exams. You will need to see an eye doctor who is trained to treat diabetic retinopathy. Begin having eye examinations as follows:
If you are beginning a new exercise program or are planning to get pregnant, have your eyes examined. Avoid resistance or high-impact exercises, which can strain already weakened blood vessels in the eyes. ReferencesRosenblatt RJ, Benson WJ. Diabetic Retinopathy. In: Yanoff M, ed. Opthalmology. 2nd ed. St. Louis, MO: Mosby; 2004;877-887. American Diabetes Association (ADA). Standards of Medical Care in Diabetes: 2009. Diabetes Care. 2009;32:S13-S61. O'Doherty M, Dooley I, Hickey-Dwyer M. Interventions for diabetic macular oedema: a systematic review of the literature. Br J Opthalmol. 2008;92:1581-1590. Diabetic Retinopathy Clinical Research Network (DRCR.net), Beck RW, Edwards AR, Aiello LP, Bressler NM, Ferris F, Glassman AR, et al. Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol. 2009;127:245-251.
Review Date:
5/20/2009 Reviewed By: Deborah Wexler, MD, Assistant Professor of Medicine, Harvard Medical School, Endocrinologist, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc. The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-
A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
|
||||||||||||||||||||||











